(Q36043541)

11 August 2017

1 reference

title

Emesis induced by low or minimal emetic risk chemotherapy (English)

1 reference

11 August 2017

1 reference

Maurizio Tonato

1

1 reference

11 August 2017

Rebecca A Clark-Snow

2

1 reference

11 August 2017

David Osoba

3

1 reference

11 August 2017

Albano Del Favero

4

1 reference

11 August 2017

Enzo Ballatori

5

1 reference

11 August 2017

Sussanne Borjeson

6

1 reference

11 August 2017

publication date

18 November 2004

1 reference

Supportive Care in Cancer

11 August 2017

published in

1 reference

11 August 2017

volume

13

1 reference

11 August 2017

issue

2

1 reference

11 August 2017

page(s)

109-111

1 reference

Transferability to clinical practice of the results of controlled clinical trials: the case of antiemetic prophylactic treatment for cancer chemotherapy-induced nausea and vomiting. Italian Group for Antiemetic Research

11 August 2017

cites work

1 reference

12 December 2020

Recommendations for the use of antiemetics: evidence-based, clinical practice guidelines. American Society of Clinical Oncology

1 reference

12 December 2020

Transferring scientific evidence to oncological practice: a trial on the impact of three different implementation strategies on antiemetic prescriptions

1 reference

12 December 2020

Is an antiemetic prophylactic treatment needed for patients submitted to consecutive days of 5-fluorouracil? An observational study

1 reference

12 December 2020

Prevention of chemotherapy- and radiotherapy-induced emesis: results of Perugia Consensus Conference. Antiemetic Subcommittee of the Multinational Association of Supportive Care in Cancer (MASCC)

1 reference

12 December 2020

10.1007/S00520-004-0703-5

Identifiers

DOI

1 reference

11 August 2017

1 reference